Showing 11,641 - 11,660 results of 103,572 for search '(( 5 ((we decrease) OR (a decrease)) ) OR ( 50 ((mean decrease) OR (teer decrease)) ))', query time: 1.43s Refine Results
  1. 11641

    Adenosine decreases the amplitude of evoked AMPA EPSCs via activation of A<sub>1</sub> ARs without altering that of the evoked IPSCs recorded from layer III pyramidal neurons in th... by Shouping Wang (402959)

    Published 2013
    “…<b>F,</b> Bath application of dipyridamole (1 µM), an adenosine transporter inhibitor, significantly reduced the evoked EPSCs (n = 10, p<0.001, paired t-test) suggesting that endogenously released adenosine decreases AMPA EPSCs. <b>G,</b> Prior application of DPCPX, an A<sub>1</sub> AR blocker, blocked dipyridamole-induced depression of AMPA EPSCs (n = 5, p = 0.85 vs. baseline, paired t-test) suggesting that the inhibitory effect of dipyridamole is mediated via activation of A<sub>1</sub> ARs. …”
  2. 11642

    <i>TUFT1</i>, a novel candidate gene for metatarsophalangeal osteoarthritis, plays a role in chondrogenesis on a calcium-related pathway by Eeva Sliz (3927023)

    Published 2017
    “…The variant reduced <i>TUFT1</i> mRNA and tuftelin protein expression in HEK293 cells. ATDC5 cells overexpressing wild type (wt) or mutant <i>TUFT1</i> were cultured in calcifying conditions and chondrogenic differentiation was found to be inhibited in both cell populations, as indicated by decreased marker gene expression when compared with the empty vector control cells. …”
  3. 11643
  4. 11644
  5. 11645
  6. 11646
  7. 11647
  8. 11648

    Edited P19 cells exhibited higher β-catenin/TCF transcription, as well as increased survivin/BIRC5 expression. by Masaya Ono (233238)

    Published 2018
    “…Expression of survivin/BIRC5 mRNA, which is highly dependent on CBP, was enhanced by Wnt3a in wild type (WT) and to a lesser extent in p300 edited P19 cells. …”
  9. 11649

    Cx46, Cx50 and Cx43 expression in wild type mice and in leptin receptor- (<i>db/db</i>) and leptin- (<i>ob/ob</i>) deficient male mice. by María Leiza Vitale (4287994)

    Published 2017
    “…<u>Cx50</u>: Total Cx50 levels showed little change in <i>db/db</i> and <i>ob/ob</i> mice compared to WT. …”
  10. 11650
  11. 11651
  12. 11652

    Respiratory network responses to systemic 5-HT<sub>2A</sub>R and 5-HT<sub>2B</sub>R antagonist applications of in situ rats. by Marcus Niebert (183419)

    Published 2013
    “…We interpret these findings as constitutive activity of 5-HT<sub>2A</sub>R.…”
  13. 11653
  14. 11654
  15. 11655
  16. 11656
  17. 11657

    Data_Sheet_5_Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network... by Fen Cao (4496014)

    Published 2023
    “…To compare the effectiveness and safety of endothelin receptor antagonists (ERAs), phosphodiesterase type 5 Inhibitors (PDE-5i), and prostaglandins (ProA) in the treatment of pediatric PAH, we investigated six hemodynamic parameters, four respiratory parameters, intensive care unit (ICU) stay duration, length of hospital stay, and two safety outcomes.…”
  18. 11658
  19. 11659
  20. 11660